REVA Extends Technological Lead in Bioresorbable Scaffolds With CE Mark Approval of the Full Fantom® Encore Product Line
June 18, 2018 19:47 ET
|
REVA Medical Inc
SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced it has...
Fantom’s Positive Two-Year Results Show Sustained Safety and Efficacy
May 23, 2018 08:21 ET
|
REVA Medical Inc
SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, reported sustained...
REVA Announces First Implants of the Fantom Bioresorbable Scaffold in Turkey
May 15, 2018 20:03 ET
|
REVA Medical Inc
SAN DIEGO, May 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced today launch...
REVA to Hold Annual General Meeting of Stockholders
May 09, 2018 19:29 ET
|
REVA Medical Inc
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold its 2018 Annual General Meeting of Stockholders (the “AGM”) on Wednesday, May 16, 2018 at...
REVA Medical Reports First Quarter 2018 Financial Results
May 09, 2018 09:00 ET
|
REVA Medical Inc
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported...
REVA to Hold First Quarter 2018 Financial Results Call
May 01, 2018 18:57 ET
|
REVA Medical Inc
SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) has scheduled a conference call to review its first quarter 2018 financial results and provide a...
REVA to Present Full Two-Year FANTOM II Data at EuroPCR
April 16, 2018 19:34 ET
|
REVA Medical Inc
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced that it will...
REVA Initiates Commercial Distribution Partnership in Turkey
April 02, 2018 19:30 ET
|
REVA Medical Inc
SAN DIEGO, April 02, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced that it will...
REVA Announces First Implant of the Fantom Encore Bioresorbable Scaffold in Switzerland
March 27, 2018 18:46 ET
|
REVA Medical Inc
SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced the first...
REVA Medical Reports Fourth Quarter and Full Year 2017 Financial Results
March 07, 2018 15:50 ET
|
REVA Medical Inc
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported...